OMIC technologies – such as genomics, metagenomics, lipidomics, transcriptomics, proteomics, metabolomics, and epigenomics – are essential tools for deeply understanding the biological complexity of diseases like IBD and for guiding the development of new therapies.

In the context of preclinical research, OMIC technologies allow us to:

    🧬 – Identify new biomarkers for diagnosis, prognosis, and prediction of therapeutic response

    🧪 – Understand the molecular mechanisms underlying diseases, including inflammatory, oncological, or degenerative processes

    🔬 – Precisely characterize preclinical models, making them more predictive and clinically relevant

    💉 – Guide personalized medicine approaches through integrated analysis of multi-omic data.